Articles related to THYROID DISEASE

The FDA classified a recall of thyroid tablets USP 30 mg as Class I after identification of a superpotent product lot. The recall affects 1,955 bottles and carries risk of serious adverse health consequences, making prompt inventory review and product removal necessary.

The American Thyroid Association released updated evidence-based recommendations for thyroid disease in preconception, pregnancy, and postpartum, incorporating new trial data on LT4 treatment thresholds, TPOAb management, and ATD safety that diverge meaningfully from 2017 guidance.

The recall was initiated because the medication content of the recalled pills is ‘below the approved specification’.

“Many factors external to the thyroid gland can modulate these diverse effects, making it difficult to assess the thyroid status of patients solely on clinical grounds.”

23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.

Hashimoto’s Thyroiditis is linked to a complex array of symptoms ranging from thyroid enlargement and systemic metabolic disruptions to severe fatigue and cognitive decline, highlighting the need for comprehensive diagnostic strategies and personalized treatment plans.